InsiderTrades.com logo
First JFK… next Elon?
From Porter & Company   |   Ad
Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.
I share with you in this special investigative documentary.
Justin Klee net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Justin Klee Biography and Net Worth

Co-Founder of Amylyx Pharmaceuticals
Justin Klee co-founded Amylyx Pharmaceuticals in 2013 and continues to serve as its Co-CEO and Co-Founder. Justin has overseen the development of Amylyx’s novel platform and therapeutic for neurodegenerative diseases from initial testing through clinical trials. Justin previously did research in neural systems while at Brown University and in neurophysiology and Alzheimer’s disease at Harvard Medical School. He received his Bachelor of Science in Neuroscience from Brown University.

How old is Justin Klee?

Mr. Klee is currently 33 years old. There are 4 older executives and no younger executives at Amylyx Pharmaceuticals. The oldest executive at Amylyx Pharmaceuticals is Dr. Camille L. Bedrosian M.D., Chief Medical Officer, who is 71 years old. Learn More on Justin Klee's age.

How do I contact Justin Klee?

The corporate mailing address for Mr. Klee and other Amylyx Pharmaceuticals executives is , , . Amylyx Pharmaceuticals can also be reached via phone at 617-682-0917 and via email at [email protected]. Learn More on Justin Klee's contact information.

Has Justin Klee been buying or selling shares of Amylyx Pharmaceuticals?

Justin Klee has not been actively trading shares of Amylyx Pharmaceuticals during the last quarter. Learn More on Justin Klee's trading history.

Who are Amylyx Pharmaceuticals' active insiders?

Amylyx Pharmaceuticals' insider roster includes Joshua Cohen (Co-Founder), and Justin Klee (Co-Founder). Learn More on Amylyx Pharmaceuticals' active insiders.

Are insiders buying or selling shares of Amylyx Pharmaceuticals?

In the last year, Amylyx Pharmaceuticals insiders bought shares 3 times. They purchased a total of 142,750 shares worth more than $326,397.50. In the last year, insiders at the sold shares 10 times. They sold a total of 62,160 shares worth more than $494,508.16. The most recent insider tranaction occured on September, 30th when CEO Justin B Klee sold 18,589 shares worth more than $59,484.80. Insiders at Amylyx Pharmaceuticals own 11.7% of the company. Learn More about insider trades at Amylyx Pharmaceuticals.

Information on this page was last updated on 9/30/2024.

Justin Klee Insider Trading History at Amylyx Pharmaceuticals

See Full Table

Justin Klee Buying and Selling Activity at Amylyx Pharmaceuticals

This chart shows Mr. Justin Klee's buying and selling at Amylyx Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Amylyx Pharmaceuticals Company Overview

Amylyx Pharmaceuticals logo
Amylyx Pharmaceuticals, Inc., a commercial-stage biotechnology company, engages in the discovery and development of treatment for amyotrophic lateral sclerosis (ALS) and neurodegenerative diseases. The company's products include RELYVRIO, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of ALS in adults in the United States and marketed as ALBRIOZA for the treatment of ALS in Canada. It is also developing AMX0114 for other neurodegenerative diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Read More

Today's Range

Now: $4.06
Low: $3.96
High: $4.15

50 Day Range

MA: $5.08
Low: $3.55
High: $7.03

2 Week Range

Now: $4.06
Low: $1.58
High: $19.95

Volume

134,550 shs

Average Volume

1,919,536 shs

Market Capitalization

$278.30 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
First JFK… next Elon?
From Porter & Company   |   Ad
Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.
I share with you in this special investigative documentary.